HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert M Strieter Selected Research

Interleukin-8B Receptors

3/2011Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer.
11/2005CXCR2/CXCR2 ligand biological axis impairs alveologenesis during dsRNA-induced lung inflammation in mice.
9/2005CD14 deficiency leads to increased MIP-2 production, CXCR2 expression, neutrophil transmigration, and early death in pneumococcal infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert M Strieter Research Topics

Disease

48Neoplasms (Cancer)
05/2015 - 11/2002
20Neoplasm Metastasis (Metastasis)
01/2014 - 06/2003
17Inflammation (Inflammations)
01/2021 - 06/2002
14Lung Neoplasms (Lung Cancer)
04/2015 - 11/2003
12Infections
01/2020 - 11/2002
12Pulmonary Fibrosis (Fibrosing Alveolitis)
11/2017 - 04/2002
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2014 - 06/2003
9Bronchiolitis Obliterans Syndrome
08/2011 - 02/2002
8Fibrosis (Cirrhosis)
01/2021 - 07/2002
6Vascular Remodeling
01/2011 - 09/2003
6Carcinogenesis
04/2008 - 03/2004
6Lung Injury
07/2007 - 12/2002
5Idiopathic Pulmonary Fibrosis
11/2009 - 07/2004
5Hypoxia (Hypoxemia)
08/2009 - 06/2005
5Renal Cell Carcinoma (Grawitz Tumor)
06/2008 - 10/2005
4Pancreatic Neoplasms (Pancreatic Cancer)
05/2015 - 09/2006
3Asthma (Bronchial Asthma)
01/2020 - 08/2007
3Sickle Cell Anemia (Hemoglobin S Disease)
11/2017 - 07/2009
3Virus Diseases (Viral Diseases)
05/2015 - 01/2005
3Lung Diseases (Lung Disease)
12/2014 - 10/2003
3Anthrax
10/2011 - 04/2009
3Melanoma (Melanoma, Malignant)
11/2010 - 06/2007
3Pneumonia (Pneumonitis)
02/2010 - 11/2005
3Carcinoma (Carcinomatosis)
06/2007 - 11/2003
3Adenocarcinoma
04/2006 - 11/2003
3Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
04/2006 - 12/2002
3Necrosis
02/2006 - 01/2002
2Wounds and Injuries (Trauma)
01/2021 - 11/2008
2Myocardial Infarction
01/2016 - 10/2012
2Hyperlipidemias (Hyperlipidemia)
10/2012 - 01/2011
2Breast Neoplasms (Breast Cancer)
01/2012 - 06/2003
2Granuloma
04/2011 - 04/2002
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2011 - 11/2008
2Reperfusion Injury
01/2010 - 11/2005
2Disease Progression
04/2009 - 04/2006
2Colitis
04/2009 - 02/2004
2Pathologic Neovascularization
11/2008 - 05/2007
2Atherosclerosis
11/2008 - 03/2004
2Ventilator-Induced Lung Injury
08/2006 - 12/2002
2Acute Lung Injury
04/2006 - 06/2005
1Cicatrix (Scar)
01/2021
1Keloid
01/2021

Drug/Important Bio-Agent (IBA)

46ChemokinesIBA
01/2021 - 04/2002
33CXC ChemokinesIBA
03/2011 - 06/2002
27LigandsIBA
01/2012 - 06/2002
17Biological ProductsIBA
01/2021 - 06/2003
16CytokinesIBA
01/2020 - 11/2002
12Chemokine ReceptorsIBA
01/2014 - 03/2003
11Biomarkers (Surrogate Marker)IBA
01/2020 - 02/2002
7Chemotactic FactorsIBA
01/2021 - 04/2002
7Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2002
6Transforming Growth Factor beta (TGF-beta)IBA
11/2009 - 04/2002
5InterferonsIBA
01/2011 - 06/2002
5CXCR4 Receptors (CXCR4 Receptor)IBA
08/2009 - 06/2003
5Bleomycin (Blenoxane)FDA LinkGeneric
08/2009 - 04/2002
4CollagenIBA
01/2021 - 07/2004
4Interleukin-12 (IL 12)IBA
04/2015 - 04/2004
4Messenger RNA (mRNA)IBA
07/2011 - 03/2003
4CC ChemokinesIBA
04/2011 - 12/2003
4AntigensIBA
11/2010 - 01/2006
4Interleukin-7 (Interleukin 7)IBA
06/2009 - 04/2002
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2008 - 06/2005
3Interleukin-10 (Interleukin 10)IBA
04/2015 - 12/2003
3Interleukin-8B ReceptorsIBA
03/2011 - 09/2005
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2009 - 11/2002
3ProstaglandinsIBA
03/2006 - 12/2003
3Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
11/2005 - 12/2003
3Interleukin-8 (Interleukin 8)IBA
06/2004 - 11/2002
2Chemokine CXCL10IBA
01/2012 - 10/2011
2Carrier Proteins (Binding Protein)IBA
03/2011 - 11/2008
2Heparin (Liquaemin)FDA LinkGeneric
03/2011 - 11/2008
2Interferon-gamma (Interferon, gamma)IBA
07/2009 - 07/2004
2Indicators and Reagents (Reagents)IBA
04/2009 - 04/2006
2Antigen Receptors (Antigen Receptor)IBA
10/2007 - 06/2004
2Interleukin-2 (IL2)IBA
05/2007 - 02/2006
2Tumor Viral Antigens (Large T Antigen)IBA
03/2006 - 11/2003
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2006 - 04/2004
2InterleukinsIBA
03/2006 - 11/2003
2Chemokine CCL21IBA
03/2006 - 04/2004
2CXCR3 ReceptorsIBA
03/2006 - 06/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2005 - 04/2002
2Neutralizing AntibodiesIBA
11/2005 - 02/2004
2Poly CIBA
11/2005 - 01/2005
2AntibodiesIBA
09/2005 - 06/2003
2Oxygen (Dioxygen)IBA
06/2005 - 03/2004
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
03/2004 - 12/2003
2Dinoprostone (PGE2)FDA Link
12/2003 - 11/2003
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2016
1Antiviral Agents (Antivirals)IBA
05/2015
1Tretinoin (Retinoic Acid)FDA LinkGeneric
05/2015
1Transforming Growth Factors (Transforming Growth Factor)IBA
05/2015
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
05/2015
15'-N-methylcarboxamideadenosineIBA
04/2015

Therapy/Procedure

12Therapeutics
05/2015 - 06/2003
8Lung Transplantation
08/2011 - 02/2002
5Immunotherapy
03/2006 - 11/2003
2Punctures
07/2011 - 10/2003
2Ligation
07/2011 - 10/2003
2Drug Therapy (Chemotherapy)
04/2009 - 09/2008